Understanding Current Acid Reflux Treatment Options
Why Ranitidine Was Withdrawn
Ranitidine, previously marketed as Zantac, was withdrawn from the UK market in 2019 due to concerns about NDMA (N-nitrosodimethylamine) contamination. This H2 receptor antagonist had been widely used for treating acid reflux and heartburn for decades. The withdrawal left many patients seeking alternative acid reflux therapy options.
Proton Pump Inhibitors as Primary Treatment
Omeprazole 20mg has become the most commonly prescribed acid reflux therapy following ranitidine's withdrawal. Unlike ranitidine, which blocked histamine receptors, omeprazole works by directly inhibiting the proton pump responsible for acid production. This mechanism typically provides more comprehensive acid suppression than H2 blockers achieved.
EverydayMeds stocks omeprazole 20mg capsules alongside branded alternatives like Losec MUPS. These treatments may be more effective for moderate to severe GORD symptoms than ranitidine was for many patients. Clinical studies suggest PPIs reduce stomach acid production by up to 95%, compared to approximately 70% reduction seen with H2 blockers.
Alternative PPI Options
Beyond omeprazole, several other proton pump inhibitors offer effective acid reflux therapy. Lansoprazole 15mg provides similar benefits with potentially faster onset of action. Pantoprazole 20mg and esomeprazole represent additional options for patients who may not respond optimally to omeprazole.
Each PPI has slightly different pharmacological properties, though all work through the same basic mechanism. Some patients find one PPI more effective than others, making treatment individualisation important.
H2 Blocker Alternatives
For patients preferring H2 receptor antagonists similar to ranitidine, famotidine remains available. This medication works through the same mechanism ranitidine used but without the contamination concerns. Famotidine may be suitable for mild symptoms or patients experiencing side effects from PPIs.
Choosing the Right Treatment
Treatment selection depends on symptom severity, frequency, and individual response. Occasional heartburn might respond well to short-term omeprazole use, whilst chronic GORD typically requires ongoing acid reflux therapy. EverydayMeds consultation service helps patients identify appropriate treatment options based on their specific needs.
Cost considerations also matter. Generic omeprazole typically costs less than branded alternatives whilst providing equivalent therapeutic benefits. This makes it an accessible option for many patients requiring regular acid reflux therapy.
